Evidence map›Paper›PMID 29093815›Full record

ArticleCancer & metabolism2017

Metabolomics guided pathway analysis reveals link between cancer metastasis, cholesterol sulfate, and phospholipids.

Caroline H Johnson, Antonio F Santidrian, Sarah E LeBoeuf, Michael E Kurczy, Nicholas J W Rattray, Zahra Rattray, Benedikt Warth, Melissa Ritland, Linh T Hoang, Celine Loriot and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cancer & metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Endocrine-disrupting compounds and metabolomic reprogramming in breast cancer.Journal of biochemical and molecular toxicology · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Caroline H Johnson *Scripps Center for Metabolomics, The Scripps Research Institute, La Jolla, CA USA.ORCID 0000-0002-7414-2154
Antonio F Santidrian *Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA USA.
Sarah E LeBoeufDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA USA.
Michael E KurczyScripps Center for Metabolomics, The Scripps Research Institute, La Jolla, CA USA.
Nicholas J W RattrayDepartment of Environmental Health Sciences, Yale School of Public HealthYale School of Medicine, New Haven, CT USA.
Zahra RattrayDepartment of Therapeutic Radiology, Yale School of Medicine, Yale University, New Haven, CT 06520 USA.
Benedikt WarthScripps Center for Metabolomics, The Scripps Research Institute, La Jolla, CA USA.
Melissa RitlandDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA USA.
Linh T HoangScripps Center for Metabolomics, The Scripps Research Institute, La Jolla, CA USA.
Celine LoriotDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA USA.
Jason HigaDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA USA.
James E HansenYale Cancer Center, Yale School of Medicine, New Haven, CT USA.
Brunhilde H FeldingDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA USA.
Gary SiuzdakScripps Center for Metabolomics, The Scripps Research Institute, La Jolla, CA USA.
Scripps Research Institute · USYale University · USYale Cancer Center · US

Funding

Pharmacokinetics and Drug-Drug InteractionsP01DA028555 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ALNOUTI, YAZEN · 2010 to 2019
$16.8M
Normalizing Breast Cancer Metabolism to Prevent Progression and Recurrence (PQ21)R01CA170737 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI FELDING, BRUNIE H. · 2012 to 2015
$2.1M
XCMS Metabolomic Data TechnologyR01GM114368 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SIUZDAK, GARY E · 2015 to 2018
$1.5M
NCI NIH HHS R01 CA170737NIDA NIH HHS P01 DA028555NIGMS NIH HHS R01 GM114368
6 · The paper itself

Abstract

backgroundCancer cells that enter the metastatic cascade require traits that allow them to survive within the circulation and colonize distant organ sites. As disseminating cancer cells adapt to their changing microenvironments, they also modify their metabolism and metabolite production.

methodsA mouse xenograft model of spontaneous tumor metastasis was used to determine the metabolic rewiring that occurs between primary cancers and their metastases. An "autonomous" mass spectrometry-based untargeted metabolomic workflow with integrative metabolic pathway analysis revealed a number of differentially regulated metabolites in primary mammary fat pad (MFP) tumors compared to microdissected paired lung metastases. The study was further extended to analyze metabolites in paired normal tissues which determined the potential influence of metabolites from the microenvironment.

resultsMetabolomic analysis revealed that multiple metabolites were increased in metastases, including cholesterol sulfate and phospholipids (phosphatidylglycerols and phosphatidylethanolamine). Metabolite analysis of normal lung tissue in the mouse model also revealed increased levels of these metabolites compared to tissues from normal MFP and primary MFP tumors, indicating potential extracellular uptake by cancer cells in lung metastases. These results indicate a potential functional importance of cholesterol sulfate and phospholipids in propagating metastasis. In addition, metabolites involved in DNA/RNA synthesis and the TCA cycle were decreased in lung metastases compared to primary MFP tumors.

conclusionsUsing an integrated metabolomic workflow, this study identified a link between cholesterol sulfate and phospholipids, metabolic characteristics of the metastatic niche, and the capacity of tumor cells to colonize distant sites.

Indexed as

Autonomous metabolomicsCancerCholesterol sulfateMetastasisMummichogPhospholipidsXCMS

Identifiers

PMID29093815
PMCPMC5663111
OpenAlexW2767189353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.